rts logo

Are we looking at the next big move in Bristol-Myers Squibb Co. (BMY)?

Bristol-Myers Squibb Co. (NYSE: BMY) is -12.86% lower on its value in year-to-date trading and has touched a low of $43.33 and a high of $68.46 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BMY stock was last observed hovering at around $45.06 in the last trading session, with the day’s loss setting it -0.35%.

Currently trading at $44.71, the stock is -2.45% and -9.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.15 million and changing -0.78% at the moment leaves the stock -15.78% off its SMA200. BMY registered -34.31% loss for a year compared to 6-month loss of -11.66%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -7.83% gain in the last 1 month and extending the period to 3 months gives it a -8.21%, and is 1.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.96% over the week and 1.96% over the month.

Bristol-Myers Squibb Co. (BMY) has around 34100 employees, a market worth around $90.63B and $45.53B in sales. Fwd P/E is 6.44. Profit margin for the company is -13.50%. Distance from 52-week low is 3.18% and -34.69% from its 52-week high. The company has generated returns on investments over the last 12 months (-9.10%).

The EPS is expected to shrink by -92.89% this year.

Bristol-Myers Squibb Co. (BMY) Top Institutional Holders

The shares outstanding are 2.03B, and float is at 2.03B with Short Float at 1.38%.

Bristol-Myers Squibb Co. (BMY) Insider Activity

The most recent transaction is an insider purchase by BOERNER CHRISTOPHER S.,the company’sChief Executive Officer. SEC filings show that BOERNER CHRISTOPHER S. bought 2,000 shares of the company’s common stock on Dec 05 ’23 at a price of $49.78 per share for a total of $99560.0. Following the purchase, the insider now owns 82672.0 shares.

Bristol-Myers Squibb Co. disclosed in a document filed with the SEC on Nov 28 ’23 that BOERNER CHRISTOPHER S. (Chief Executive Officer) bought a total of 3,071 shares of the company’s common stock. The trade occurred on Nov 28 ’23 and was made at $48.86 per share for $0.15 million. Following the transaction, the insider now directly holds 79384.0 shares of the BMY stock.

Still, SEC filings show that on Nov 20 ’23, Samuels Theodore R. II (Director) acquired 8,500 shares at an average price of $49.81 for $0.42 million. The insider now directly holds 35,500 shares of Bristol-Myers Squibb Co. (BMY).

Related Posts